Dynamic Technology Lab Private Ltd bought a new stake in shares of LifePoint Health, Inc. (NASDAQ:LPNT) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 12,978 shares of the company’s stock, valued at approximately $872,000.

Several other hedge funds have also made changes to their positions in the company. WINTON GROUP Ltd boosted its holdings in shares of LifePoint Health by 138.4% during the 2nd quarter. WINTON GROUP Ltd now owns 93,705 shares of the company’s stock valued at $6,292,000 after buying an additional 54,400 shares in the last quarter. Dean Capital Management boosted its holdings in shares of LifePoint Health by 68.0% during the 2nd quarter. Dean Capital Management now owns 67,143 shares of the company’s stock valued at $4,508,000 after buying an additional 27,180 shares in the last quarter. Ameritas Investment Partners Inc. boosted its holdings in shares of LifePoint Health by 2.6% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 12,080 shares of the company’s stock valued at $811,000 after buying an additional 305 shares in the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of LifePoint Health by 2.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 59,357 shares of the company’s stock valued at $3,986,000 after buying an additional 1,629 shares in the last quarter. Finally, Cubist Systematic Strategies LLC bought a new stake in shares of LifePoint Health during the 2nd quarter valued at $419,000. Hedge funds and other institutional investors own 99.53% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Dynamic Technology Lab Private Ltd Takes Position in LifePoint Health, Inc. (LPNT)” was reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.dailypolitical.com/2017/10/17/dynamic-technology-lab-private-ltd-takes-position-in-lifepoint-health-inc-lpnt.html.

LifePoint Health, Inc. (NASDAQ:LPNT) remained flat at $55.80 during trading on Tuesday. 76,964 shares of the stock were exchanged. LifePoint Health, Inc. has a 52 week low of $50.60 and a 52 week high of $70.95. The stock’s 50 day moving average is $56.57 and its 200 day moving average is $61.04. The company has a market capitalization of $2.24 billion, a price-to-earnings ratio of 12.49 and a beta of 0.84.

LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.06. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The company’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter last year, the company earned $0.69 earnings per share. On average, equities analysts forecast that LifePoint Health, Inc. will post $4.06 EPS for the current fiscal year.

A number of brokerages have recently commented on LPNT. BidaskClub cut shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Saturday, July 8th. Royal Bank Of Canada reiterated a “buy” rating and issued a $77.00 price target on shares of LifePoint Health in a research note on Wednesday, July 5th. Zacks Investment Research upgraded shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 price target on the stock in a research note on Tuesday, July 4th. TheStreet cut shares of LifePoint Health from a “b-” rating to a “c+” rating in a research note on Wednesday, August 16th. Finally, ValuEngine cut shares of LifePoint Health from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have issued a buy rating to the company. LifePoint Health presently has an average rating of “Hold” and a consensus target price of $65.54.

LifePoint Health Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.